🇺🇸 LLY — Eli Lilly and Company

Healthcare Compra
← Volver

Precio actual

1.149,36 USD

Máx. histórico

1.292,65

16 días

Split 2:1 del 16/10/1997

Caída desde máximo

-11,08%

Rango 52 semanas

712,05 – 1.292,65

Variación hoy

-0,88%

Cierre anterior

1.159,60

Rango de hoy

1.138,31 – 1.158,43

Volumen hoy

2.159.931

Información
Nombre completo
Eli Lilly and Company
Divisa
USD
Mercado
NYSE
Sector
Healthcare
Industria
Drug Manufacturers - General
Empleados
50.000
PER ⓘ
38,61 (puede no estar actualizado)
Dividend yield
0,60% (puede no estar actualizado)
Precio objetivo analistas
1.315,56 USD (puede no estar actualizado)
Primera cotización
01/06/1972
Precio actualizado
hace 3 días
Sobre la empresa

Eli Lilly and Company discovers, develops, manufactures, and markets human pharmaceutical products in the United States, Europe, China, Japan, and internationally. The company offers cardiometabolic health products, including Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, Humulin U-500 for diabetes; Jardiance, Mounjaro, and Trulicity for type 2 diabetes; and Zepbound for obesity. It also provides oncology products, such as Cyramza for the second-line treatment of gastric cancer or gastro-esophageal junction adenocarcinoma; Erbitux for colorectal cancers and head and neck cancers; Inluriyo for breast cancer; Jaypirca for chronic lymphocytic leukemia or small lymphocytic lymphoma; Retevmo for the treatment of metastatic NSCLC; TYVYT for classic hodgkin's lymphoma; and Verzenio for breast cancer. In addition, the company offers immunology products, which include Ebglyss for severe atopic dermatitis; Olumiant for rheumatoid arthritis, atopic dermatitis, severe alopecia areata, and COVID-19; Omvoh for ulcerative colitis; and Taltz for plaque psoriasis, psoriatic arthritis, ankylosing spondylitis, and non-radiographic axial spondylarthritis. Further, it provides Emgality for migraine prevention and episodic cluster headache, as well as Kisubla for symptomatic Alzheimer's disease. The company has collaborations with Boehringer Ingelheim Pharmaceuticals, Inc. for the Jardiance product family; and F. Hoffmann-La Roche Ltd and Genentech, Inc. for lebrikizumab, as well as license agreements with Almirall, S.A. for Ebglyss; and Chugai Pharmaceutical Co., Ltd for orforglipron; strategic collaboration with Ascidian Therapeutics for development of therapies for undisclosed monogenic kidney diseases; and BioArctic AB (publ) for new treatment. Eli Lilly and Company was founded in 1876 and is headquartered in Indianapolis, Indiana.

Dividendos repartidos Total últimos 12 meses: 6,6900 USD · Yield: 0,58%
Fecha de pago Importe por participación
14/08/2026 1,7300 USD
15/05/2026 1,7300 USD
13/02/2026 1,7300 USD
14/11/2025 1,5000 USD
15/08/2025 1,5000 USD
16/05/2025 1,5000 USD
14/02/2025 1,5000 USD
15/11/2024 1,3000 USD
15/08/2024 1,3000 USD
15/05/2024 1,3000 USD
14/02/2024 1,3000 USD
14/11/2023 1,1300 USD
14/08/2023 1,1300 USD
12/05/2023 1,1300 USD
14/02/2023 1,1300 USD
Splits Registrados en el histórico de precios
Fecha Ratio
16/10/1997 2:1
21/12/1995 2:1
01/05/1989 2:1
30/01/1986 2:1
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
11/07/2006 55,89 56,21 55,36 55,93 -0,60% 1,52% 2.715.500
10/07/2006 56,36 56,55 55,97 56,27 +0,05% 1,03% 1.547.500
07/07/2006 56,74 56,97 56,02 56,24 -0,76% 1,67% 2.356.100
06/07/2006 56,10 56,83 56,10 56,67 +0,80% 1,30% 2.662.500
05/07/2006 56,21 56,67 56,00 56,22 +0,97% 1,19% 5.506.200
03/07/2006 55,42 55,90 55,27 55,68 +0,74% 1,14% 1.312.600
30/06/2006 54,54 55,66 54,40 55,27 +1,36% 2,31% 4.833.000
29/06/2006 53,60 54,71 53,50 54,53 +2,04% 2,26% 3.866.900
28/06/2006 53,50 53,78 53,25 53,44 -0,06% 0,99% 2.317.300
27/06/2006 54,24 54,24 53,22 53,47 -1,69% 1,88% 3.313.900
26/06/2006 54,09 54,39 53,83 54,39 +0,17% 1,04% 1.951.900
23/06/2006 54,35 54,44 53,80 54,30 -0,53% 1,18% 2.652.600
22/06/2006 54,71 54,86 54,34 54,59 -0,26% 0,95% 2.529.600
21/06/2006 54,70 54,99 54,52 54,73 -0,29% 0,86% 3.382.000
20/06/2006 54,45 55,08 54,40 54,89 +0,73% 1,25% 3.745.100
19/06/2006 54,48 54,57 54,25 54,49 +0,44% 0,59% 3.272.100
16/06/2006 53,92 54,42 53,90 54,25 +0,37% 0,96% 4.044.700
15/06/2006 53,53 54,14 53,33 54,05 +1,66% 1,51% 4.846.100
14/06/2006 52,25 53,41 52,00 53,17 +3,02% 2,70% 6.665.000
13/06/2006 51,80 52,24 51,54 51,61 +0,00% 1,35% 3.847.000
12/06/2006 52,28 52,36 51,56 51,61 -0,25% 1,53% 3.112.300
09/06/2006 51,75 52,09 51,45 51,74 -0,04% 1,24% 2.365.400
08/06/2006 51,40 51,81 50,89 51,76 +0,10% 1,79% 5.038.800
07/06/2006 51,16 51,93 51,05 51,71 +1,09% 1,72% 3.955.300
06/06/2006 51,60 51,66 50,83 51,15 -0,39% 1,61% 3.745.700
05/06/2006 51,69 51,98 51,25 51,35 -1,31% 1,41% 3.717.500
02/06/2006 51,95 52,44 51,77 52,03 +0,08% 1,29% 3.368.000
01/06/2006 51,62 52,06 51,18 51,99 +0,68% 1,70% 3.185.900
31/05/2006 51,54 51,72 51,02 51,64 +0,39% 1,36% 3.547.100
30/05/2006 52,20 52,50 51,29 51,44 -1,59% 2,32% 3.169.400